Carbon Nanotubes and Chronic Granulomatous Disease
AbstractUse of nanomaterials in manufactured consumer products is a rapidly expanding industry and potential toxicities are just beginning to be explored. Combustion-generated multiwall carbon nanotubes (MWCNT) or nanoparticles are ubiquitous in non-manufacturing environments and detectable in vapors from diesel fuel, methane, propane, and natural gas. In experimental animal models, carbon nanotubes have been shown to induce granulomas or other inflammatory changes. Evidence suggesting potential involvement of carbon nanomaterials in human granulomatous disease, has been gathered from analyses of dusts generated in the World Trade Center disaster combined with epidemiological data showing a subsequent increase in granulomatous disease of first responders. In this review we will discuss evidence for similarities in the pathophysiology of carbon nanotube-induced pulmonary disease in experimental animals with that of the human granulomatous disease, sarcoidosis. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Barna, B.P.; Judson, M.A.; Thomassen, M.J. Carbon Nanotubes and Chronic Granulomatous Disease. Nanomaterials 2014, 4, 508-521.
Barna BP, Judson MA, Thomassen MJ. Carbon Nanotubes and Chronic Granulomatous Disease. Nanomaterials. 2014; 4(2):508-521.Chicago/Turabian Style
Barna, Barbara P.; Judson, Marc A.; Thomassen, Mary J. 2014. "Carbon Nanotubes and Chronic Granulomatous Disease." Nanomaterials 4, no. 2: 508-521.